How Pharmaceuticals are gaining from COVID-19?

Headline Diplomat eJournal - Issue 1, Series 2
The perilous lenses of COVID-19: The sociopolitical impact
Writes Edwin Oedipo, Content Writer, Headline Diplomat eJournal, LUDCI.eu
COVID-19 has brought an unprecedented health crisis around the world. People have lost their jobs and many economic spheres have been affected deeply. However, amidst this global epidemic, one industry is not only still standing, but gaining!

The Pharmaceutical field has experienced steady growth even as other businesses are making huge losses and some are closing. According to Technavio’s custom research reports, it is forecasted that the pharmaceutical logistics market will grow due to a rise in pharmaceutical sales. Companies like Eli Lily and Gilead, are observing a positive growth in the stock market.

Many countries around the globe have adjusted their resources and pumped them into their health sectors. Of course, they need pharmaceutical products to treat COVID-19. They must buy medicine, conduct tests and search for a vaccine.

Pfizer is one of the biggest gainers from the coronavirus outbreak. Pfizer’s pneumonia vaccine Prevnar 13 has seen an unforeseen rise in sales, presumptively bec...